Published in

Royal Society of Chemistry, RSC Advances, 48(12), p. 31466-31477, 2022

DOI: 10.1039/d2ra04385h

Links

Tools

Export citation

Search in Google Scholar

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

As promising antimicrobials against MDR pathogens, two novel series of isatin thiazolyl-pyrazoline conjugates were developed. Compounds 9f and 10h were the most effective against the tested MDR strains.